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Abstract
The telomerase reverse transcriptase has an essential role in telomere mainte-
nance which is very important in aging process and cancer biology. Recent studies
have revealed three-dimensional architecture of both human and ciliate telomerase
at about 25 Å resolution, using single particle electron microscopy (EM). Telome-
rase supplements the tandem array of simple-sequence repeats at chromosome ends
to compensate for the DNA erosion inherent in genome replication which makes it
to be distinct among polymerases. Telomeres are found at the end of eukaryotic
linear chromosomes and proteins that bind to them and help to protect DNA from
being recognized as double-strand breaks thus preventing end-to-end fusions. The
activity of telomerase is tightly regulated at multiple levels of cellular development,
from transcriptional regulation of the telomerase components to holoenzyme bio-
genesis and recruitment to the telomere site for activation and processing. Com-
monly used methods in telomere biology are telomere restriction fragment (TRF),
telomere repeat amplification protocol (TRAP) and telomere dysfunction induced
foci (TIF) analysis. This chapter summarizes our current knowledge on the mecha-
nisms of telomerase recruitment and activation using insights from studies in
mammals and budding and fission yeasts. Finally, we discuss the differences in
telomere homeostasis between different cell types and non-telomerase telomere
maintenance mechanisms.
Keywords: telomerase, telomere, holoenzyme biogenesis, chromosome ends,
reverse transcriptase
1. Introduction
Telomerase is a ribonucleoprotein complex, composed of a reverse transcriptase
enzyme catalytic subunit and a long non-coding RNA that contains the template
sequence for telomere synthesis [1, 2] and is required for linear chromosome main-
tenance in most eukaryotes. The enzyme telomerase is active in germ cells and
during early embryogenesis, ensuring restoration of telomere length for the next
generation. However, when using an aged somatic cell with shortened telomeres for
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cloning, the offspring might start with a diminished replicating capability of its cells
and consequently age, or at least reach senescence, faster [3]. Telomere biology
differ significantly among mammalian species, ranging from humans with very
short telomeres and limited telomerase activity in the cells to mice with extremely
long telomeres and active telomerase in multiple tissues. Human fibroblast cells
have been reported to possess short telomeres and suppress telomerase activity [4].
Hence, human cells undergo permanent growth arrest, or replicative senescence,
which is triggered by the critically short telomeres upon serial passaging in culture
[5, 6]. Replicative senescence is an important barrier in tumor progression, as
malignant tumors must reactivate telomerase or use the alternative lengthening of
telomere mechanism to gain unlimited proliferation potential [7]. The expression of
some components of the telomerase holoenzyme is tightly regulated [8]. For
instance, in unicellular eukaryotes TERT and TER are constitutively expressed. In
mammals, TERT is expressed only in highly proliferative cells and tumor cells.
Somatic cells and cells with low proliferative capacity lack enzyme activity, this is
the reason why telomerase activity is extensively studied as a potential target for
antitumor therapy [9, 10]. However, apart from telomerase there are other mecha-
nism used to maintain chromosome length; in some organisms, such as the fruit fly
Drosophila melanogaster, retrotransposon-like elements are alternatively used to
replenish the DNA at the ends of chromosomes [11]. As reported by Miriam
Aparecida Giardini et al. [12], under certain circumstances, yeast and human cells
that lack telomerase activity, as well as some telomerase-negative tumor lineages,
are able to maintain their telomeres using a recombination-based DNA replication
mechanism known as alternative lengthening of telomeres (ALT) [13, 14].
Research conducted in the past 10 years has revealed important discoveries on
the evolution of telomere maintenance mechanisms. [15]. Telomeres serve as sub-
strates for telomerase, the enzyme responsible for adding DNA to the ends of
chromosomes, thus maintaining chromosome length [9, 16]. To compensate for the
DNA erosion inherent in genetic stability, telomerase adds tandem array of simple-
sequence repeats at the chromosome ends. The template for telomerase reverse
transcriptase is within the RNA subunit of the ribonucleoprotein complex, this
contains additional telomerase holoenzyme protein components within cells that
assemble the active ribonucleoprotein and promote its function at telomeres. In
terms of its reiterative reuse of an internal template, telomerase is different among
other polymerases [17]. Like many polymerases, telomerase catalyzes nucleotide
addition to a primer 30 hydroxyl group, forming a product-template duplex.
Accordingly, telomerase and other polymerases share a metal-dependent chemistry
of nucleotide addition. Beyond these parallels, telomerase possesses unique proper-
ties of nucleic acid handling. Accurate telomeric repeat synthesis depends on strict
boundaries of template copying within TER. Also, telomerases from most species
studied have the exceptional ability to extend a primer by processive addition of
repeats (reviewed in [17]). Repeat addition processivity (RAP) obliges dissociation
of the product-template duplex without product dissociation from the enzyme [17].
The template-dissociated single-stranded DNA must maintain template-
independent interactions while the template repositions for base pairing of its 30
end, rather than the 50 end, with the product. These coordinated nucleic acid
handling events transpire as part of the full catalytic cycle of repeat synthesis [17].
Telomeres are specialized nucleoprotein structures located at the ends of linear
chromosomes; they consist of TTAGGG repetitive sequences. They function to
prevent natural chromosomal termini from activating the DNA damage response.
[18]. The knowledge and understanding of telomerase structure, mechanism of
action and factors involved in its activity would give more insight in overcoming
the problem of replicative senescence.
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2. Telomerase organizational architecture
During the last 4 years, progress in telomere research has revealed the three-
dimensional architecture of telomerase in human and ciliate which is measured at
about 25 Å resolution, this was obtained using single particle electron microscopy
(EM). The structural analysis of the two holoenzyme complexes isolated from cells
revealed that telomerase in ciliate is monomeric while the human telomerase is
dimeric and it is only functional as a dimer [19]. Telomerase is a RNP complex with
high-molecular weight and comprises of two major components and these are;
TERC and a TERT (Figure 1) [12]. TERC is the RNA component which is essential
for telomere synthesis; this serves as a template to elongate the 30 overhang of the
telomeric G-rich strand and specifies the repeat sequence added. In vertebrates, the
TERC is comprised of three highly conserved structural domains and these are: the
template pseudoknot domain, CR4-CR5 domain, and the small Cajal-body RNA
domain. The template pseudoknot domain contains the template region for
telomeric DNA synthesis and a conserved pseudoknot structure crucial for telome-
rase activity [20, 21]. Among eukaryotes the RNA component varies dramatically in
sequence composition and in size [22–26].
TERT contains catalytic domains and is the protein component which acts as a
specialized reverse transcriptase. In humans, TERT and TERC are the components
required for telomerase activity in in vitro condition, although in in vivo condition
some proteins are associated with the holoenzyme complex and are also essential for
the catalytic function of telomerase enzyme [27]. About 32 different proteins are
associated with human telomerase in vivo so as to maintain its functionality [28];
but few of these proteins are phylogenetically conserved. Proteins associated with
telomerase activity have been best categorized in eukaryotes. Ciliate telomerase
RNPs complex comprises a telomerase-specific La motif protein that folds telome-
rase RNA into a conformation that will be recognized by the TERT component [29].
Figure 1.
Telomerase holoenzyme showing the various components. (A) Telomerase reverse transcriptase component
(TERT) and telomerase RNA component (TER). (B) Diagram representing the TERT primary structure
showing important TERT domains which include; the telomerase N-terminal domain (TEN), telomerase
RNA-binding domain (TRBD), reverse transcriptase domain (RT) and C-terminal extension region (CTE).
The position of the structural fingers, palm, and thumb subdomains are also highlighted. Openly accessed from
Miriam Aparecida Giardini et al. [12] and Nanda Kumar and Cech [34].
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At least two additional subunits, p45 and p75 are present in Tetrahymena
thermophila holoenzyme which are not considered essential for TERT RNP assem-
bly but are required for telomere elongation process. This common role is played by
the proteins Est1p and Est3p in Saccharomyces cerevisiae [30]. There has not been
any report in humans for proteins with this type of function, but known interaction
partners of human telomerase RNA (hTR) have been reported and they include
dyskerin (the H/ACA-motif RNA binding proteins), NHP2, NOP10, and GAR1.
These four proteins assemble with hTR and with large families of H/ACA-motif
small nucleolar (sno) RNAs and small Cajal body (sca) RNAs (Figure 2). Amino
acid substitutions in dyskerin reduce hTR accumulation and this give rise to the X-
linked form of dyskeratosis congenita (a bone marrow failure syndrome) [31].
Proteomics of highly purified active human telomerase led to the suggestion that
only hTERT and dyskerin are associated with hTR [28]. However, this conclusion is
challenged by previous studies showing that dyskerin possesses minimal RNA
binding affinity in the absence of its H/ACA-motif binding partners NHP2 and
NOP10 [32].
In general, telomerase RNP complexes exhibit conserved compositions and
structures, even in evolutionarily distant organisms. Their compositions are similar
from yeasts to mammals, including humans (Figure 1) [5, 12, 33].
For in vitro enzyme activity, minimal complex formation by TERT and TER
components is sufficient. Nevertheless, in vivo, enzyme biogenesis, enzyme activity,
and nucleotide addition processes also depend on other accessory proteins, indicat-
ing that a relatively complex maturation pathway is required for generation of an
active RNP that has to find its substrate [35, 36]. Telomerase function to avoid the
loss of terminal DNA, which is caused due to inability of DNA polymerases to
completely replicate the 50 ends of linear DNA molecules and also the actions of
exonucleases involved. Both processes are responsible for generation of transient
3’OH overhangs found on the opposite ends of the leading and lagging DNA
strands. The recognition of these overhangs are done by the end-binding
proteins, they bind to the overhangs and afterward recruit telomerase to elongate
the G-strand termini. The C-strand is synthesized by the conventional DNA
replication pathway as soon as the telomeres are replicated by the telomerase
[2, 14, 37, 38].
2.1 Telomerase-associated proteins
Though expression of hTERT and hTERC in rabbit reticulocyte lysates is suffi-
cient to reconstitute basic telomerase enzyme [29], but the in vivo requirements for
other factors necessary in the assembly of the active enzyme which did not clearly
revealed some of this in vitro reconstitution, even though some of these factors are
present in the rabbit reticulocyte lysates [39]. The molecular chaperones; Hsp90
and p23 are present in rabbit reticulocyte lysates. These are directly associated
with the hTERT and are necessary for telomerase activity [39]. Biochemical and
genetic studies reveal that additional protein subunits of telomerase exists which
may be involved in the biogenesis or assembly of active telomerase RNP
complex and may facilitate or regulate the access of telomerase to its substrate (i.e.
the telomeres) [39].
2.2 hTERT-associated proteins
Biochemical fractionation of telomerase activity from the yeast Tetrahymena
thermophilawas used in identifying the first telomerase-associated proteins [29, 39].
The proteins, p80 and p95, were identified by their association with the RNA
4
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component of telomerase and by copurification of telomerase activity [37]. In a
similar report,Tetrahymena strains were shown to lack p80 and p95, and the levels
of telomerase activity with its RNA appear to function totally normal. This suggests
that these proteins are not core components of telomerase and can be a separate
Figure 2.
Showing schematic structure of (A) budding yeast (S. cerevisiae) telomerase, (B) human telomerase cropped at
a telomere 3’end, and (C) vertebrate telomerase RNAs showing the conserved structural motifs. The positions of
DKC mutations in the human telomerase (hTERC) gene are shown in red. Images are adopted from
Smogorzewska and de Lange [33].
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ribonucleoprotein that was copurified nonspecifically with telomerase [40]. Never-
theless, it was reported in another study that cells devoid of p80 and p95 have their
telomeres elongated both in macronuclei and micronuclei but lose genetic content
in their micronuclei, which suggest the role of p80 and p95 proteins in micronuclear
genomic stability and telomere length maintenance [40].TEP1 (telomerase-
associated protein 1) which was identified in humans, mice and rats is the mam-
malian homolog of p80, and is involved with telomerase activity. [39]. TEP1 con-
sists of 2629 amino acids, much larger than p80. About 900 amino acids found at
the amino terminus of TEP1, contain region homologous to p80 which were found
to associate with telomerase RNA. The carboxyl terminus of TEP1 contains 12
WD40 repeats, a motif known to be involved in protein-protein interactions [39].
TEP1 expression can be distinguished in most tissues irrespective of telomerase
activity. Disturbance of mouse TEP1 has no effect on telomerase activity or telo-
mere length in spite of its association with both the RNA and catalytic components
of telomerase in cell extracts from immortalized human, mouse, and rat cells
[39, 41]. The TEP1 protein has also been recognized as a constituent of large
cytoplasmic particles called vaults, which are ribonucleoprotein complexes [39].
The functions of TEP1 in both telomerase and vaults are still not elucidated [39].
The molecular chaperone p23 was first identified to be associated with hTERT using
the amino terminus (amino acids 1–195) as the desirability in a yeast two-hybrid
screen. Consequently, it was observed that the proteins p23 and p90 were in asso-
ciation with hTERT in mammalian cells and in in vitro condition [41]. The first
identified sets of proteins which interact physically and functionally with human
telomerase is the hsp90 chaperone complex and have been found to support
complete assembly of ribonucleoprotein and the formation of active
telomerase enzyme [39]. It is well known that other reverse transcriptase that
are of viral origin also interact with hsp70, hsp90, and p23, but appear to be
transient [12].
3. Telomerase activity in different cell types
Telomeres are needed to maintain the ends of chromosomes and sustain chro-
mosome stability in eukaryotic cells. Telomeres loss their noncoding DNA
sequences in the erosion that happens during DNA replication in each cell cycle.
They do this to protect the genetic information in the chromosomes [42, 43]. Most
somatic cells enter into replicative senescence because they have undergone suffi-
cient cell divisions to cause critical shortening of the telomeres. Some cells, includ-
ing lymphocytes, germ cells, stem cells and unicellular eukaryotes such as yeast,
express the enzyme telomerase, which gives them the ability to replenish their
telomeres and give them further replicative potential [30, 44]. Most human
tumors express active telomerase enzyme making them immortal while in
differentiated cells, expression of the telomerase components is closely regulated
[45, 46]. A direct correlation between continuous cell division and telomere
length maintenance was studied in in vitro culture condition through ectopic
expression of telomerase activity in somatic cell [47]. Even though cancer cells
steadily maintain telomere length which also tend to be shortened in later stage
[48, 49], some of them are critically shortened and are termed ‘t-stumps’ [50]
resulting in immortal cells which possessed a high risk of chromosome instability.
This is extraordinarily different from our understanding of telomerase activity
in normal cells, in which telomerase acts to elongate shorter telomeres until they are
no longer short [7, 51]. The reason why telomerase behaves differently in cancer
cells still remains an area of interest for research.
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3.1 Telomerase expression and cellular proliferation
The expression of telomerase enzyme activity in different types of cells has been
characterized using the telomeric repeat amplification protocol (TRAP) assay. The
method fundamentally measures the telomerase activity confined within a cell lysate
in vitro culture [10]. By using this assay, it is well documented that most differenti-
ated somatic cells lack detectable telomerase activity [10, 46], explaining the reason
why telomeres shorten in each cell divisions [47, 48, 52]. In adult testes and ovaries,
telomerase enzyme is highly expressed thereby, allowing consistently longer telo-
meres to be inherited by the next generation [48, 53]. During the early embryonic
development, telomerase enzyme remains active but its expression declines after the
blastocyst stage and cannot be detected in neonatal somatic cells [53–55]. Telome-
rase activity is weak in most stem cell populations [10, 44, 46, 56], this is not
sufficient to immortalize cells but can extend the proliferative capacity of these cells
(reviewed in [6, 57]). Remarkably, the Hayflick limit of somatic cells can be indef-
initely avoided when telomere length is maintained by high expression of telomerase
activity [47, 58]. Therefore, the level of telomerase activity and its expression deter-
mines the level of telomere length elongation and proliferative ability of a cell.
4. Regulation of telomerase activity in mammals
Telomerase activity is widely regulated owing to its important role in the
maintenance of genome integrity. Multicellular organisms display tissue-specific,
developmental and stress response strategies for telomerase suppression [59, 60].
In human somatic cells the inactivation of telomerase enzyme and maintenance of
telomere length have been proposed to play a role as a tumor suppressor mechanism
[61, 62]. This may also be needed for cell latency, differentiation, and death of some
cell types [63]. However, collective telomere erosion limits the self-renewal ability of
highly proliferative human cell lineages in the skin and blood [29]. The expression of
TERC is universal while TERT expression is highly regulated in some organisms,
especially in mammals. Many strategies have been proposed to control telomerase
activity, because the enzyme can be regulated at various levels including expression
level. For instance, the epigenetic modification of histones can modulate chromatin
structure and the accessibility of the transcriptional machinery to regulatory regions
of target genes. In this regard, numerous transcription factors, such as c-MYC, SP1,
MAD1, and HIF-2a, have been shown to recruit either histone acetyltransferases or
histone deacetylases to the TERT promoter to control TERT expression [64, 65].
However, the transcription expression is not constantly linked with the enzyme
activity, which might result in transcription modulation failure [66]. Consequently,
telomerase is expressed in embryonic stem cells, but TERT expression and telome-
rase activity are frequently very low or undetectable in somatic cells [67]. In con-
trast, telomerase activity seems to be high in most (85–90%) cancer cells [10, 46,
68]. Nevertheless, some cells that lack telomerase activity still exhibit a high level of
hTERT transcription. In these cases, regulation at the level of alternative splicing
leads to the skipping of exons that encode reverse transcriptase function [69]. In
mice, the deletion of either TERC or TERT can result in telomere shortening, geno-
mic instability, aneuploidy, telomeric fusion, and aging-related phenotypes [41, 70].
Therefore, telomerase dysfunction may lead to defects in various highly proliferative
cells/tissues, ultimately leading to aging-related degenerative diseases [71]. The
overexpression of TERT can dramatically increase the life span of mice in the
background of the overexpression of tumor suppressor genes, such as p53, p16, and
p19, indicating that TERT must have an anti-aging activity in mammals [4, 15, 72].
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4.1 Telomere replication in the absence of telomerase
There exist some alternative mechanisms which are activated to maintain telo-
mere length in the absence of telomerase activity. These mechanisms are principally
based on recombination events that come into play to amplify or reorganize previ-
ously existing telomeric sequences [73, 74], and the mechanisms seem to be com-
plementary to both the telomerase method and the method occupied in “retro
transposition” [11]. The alternative mechanisms were first observed in budding
yeasts that were able to survive and achieve telomere elongation despite lack of a
functional telomerase [12]. Thereafter it was verified that this phenomenon is
dependent on RAD52 (a protein involved in homologous recombination) [74].
Telomere lengths are also maintained by telomerase in most cancer cells, [46].
Reports have shown that approximately 10–15% of cancer cells elongate their telo-
meres by using one or more alternative mechanisms referred to as alternative
telomere lengthening (ALT) [68, 75]. In the same way, immortalized cells can also
elongate their telomeres using either telomerase [76] or ALT [77].
Other telomere-lengthening mechanisms also exist in the absence of telome-
rase activity. These mechanisms have been reviewed in details in previous reports
[11]. The mosquito fly Anopheles gambiae, the vinegar fly Drosophila melanogaster,
and some species of plants are other examples of organisms that use alternative
telomere elongation mechanism by using recombination [11]. For instance,
Drosophila, lacks telomerase activity and exhibits long tandem arrays composed of
three non-LTR retrotransposons, HeT-A, TART, and TAHRE, instead of simple
telomeric repeats unlike in most organisms. These were the first transposable
elements revealed to play an important role in cell structure [11, 40, 78]. In
Trypanosoma brucei (a haemoparasite), critically short telomeres generated by
knocking out the TERT gene were stabilized by an unknown mechanism [79].
These short telomeres lack active transcriptional factors and tend to shorten more
and more without leading to cell senescence due to their stability regardless of the
absence of active telomerase enzyme [80, 81]. The mechanism by which these
short telomeres are stabilized has not yet been revealed, but it is known that the
telomerase-deficient strains switch variant surface genes (VSG) by duplicative
gene conversion, which occurs more frequently than in wild-type strains and
exhibit longer telomeres. Furthermore, it was observed that shorter chromosomes
at no time underwent fusion and that telomere stabilization was sufficient to
preserve genomic integrity, with no apparent effects on long-term population
growth [82].
4.2 Methods of measuring telomerase activity
Methods used for the detection of telomerase activity can be divided into two
major groups as described by Skvortsov et al. [83]: those based on direct detection of
telomerase products, (Table 1) and those based on different systems of amplification
of the signals from DNA yield from telomerase (Table 2). The methods discussed in
this chapter (Figures 3 and 4) are suitable for testing telomerase activity in different
types of samples such as; in protozoa, mammalian cells, mixed cellular populations,
and tissues [83].
4.2.1 Methods containing the amplification of telomerase-synthesized DNA with
modifications to the original TRAP
Telomeric repeat amplification protocols (TRAPs) are the most common
methods employed for detection of telomerase activity which permit one to carry out
semi-quantitative and quantitative analyses, by introducing some modifications [83].
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Figure 4.
Showing direct detection of telomerase by surface plasmon resonance (SPR) for detecting macromolecules;
(A) sensogram corresponding to the general scheme and (B) SPR sensogram for telomerase activity detection.
RU, resonance units. The difference between signals 1 and 2 represents DNA which was synthesized by
telomerase [83].
Figure 3.
Illustration showing the original telomeric repeat amplification protocol (TRAP) assay [83].
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Assay name Description of modification of original
assay
Benefits of modification Potential limitation References
Purification of telomerase-synthesized
DNA and TRAP efficiency
This method involves the extraction of
telomeric-synthesized DNA using modified
magnetic beads where PCR inhibitors are
eliminated or completely diluted. There are
three main stages involved in the extraction
process; the elongation of the substrate-
imitating oligonucleotide by telomerase, the
extraction of telomerase synthesized DNA
using modified magnetic beads and finally
the amplification step
Sensitivity towards PCR inhibitors is lower as
compared with the standard TRAP method
and its efficiency is slightly higher when
analyzing tissue and other complex
specimens
False-positive or false negative results can be
obtained, and they may affect the validity of
the diagnosis and prognosis of a disease. The
nature of specimens, such as large volumes
of fluid (blood, etc.) or presence of
numerous normal cells, may also complicate
the detection of telomerase activity
[83, 92]
Internal standards for TRAP Here, the internal standards are amplified
with the same primers as the telomerase-
synthesized DNA. This permits the presence
of Taq polymerase inhibitors (such as gem-
containing compounds) in the samples to be
analyzed and for performing of total control
of PCR. The two most common standards
used are of 36 and 150 bp in length
The 150 bp standard is more sensitive
towards the Taq polymerase inhibitors
present in the reaction mixture
There are two most common standards used,
with the length of 36 and 150 bp. The 36 bp
standard is excessively amplified if the
specimens have a low telomerase activity,
competes with the telomerase-synthesized
DNA, and provides a false negative signal
[83, 90, 93]
“Two-primer” TRAP (TRAP) with an
additional specific reverse primer
The telomerase-synthesized DNA is
amplified by the use of two reverse primers
with lengths of 20 (RP) and 38 (RPC3)
nucleotides, in the presence of [3 H]TTP or
[α-32P]dСTP
This modification of the standard TRAP is
used to reduce false signals. Here there no
electrophoretic analysis of PCR products but
instead the total radioactivity is estimated as
a decisive factor of telomerase activity
[83, 94, 95]
TRAP with fluorescence resonance
energy transfer (FRET)
This method uses primers with an energy
transfer (amplifluors) property instead of
the normal primers used for amplification of
the telomerase-synthesized DNA
The advantage of this modification is that the
replacement of the telomerase substrate and
reverse primer by amplifluors allows to
achieve an increasingly high intensity of the
fluorescent signal
[93, 96, 97]
TRAP with detection using a
Scintillation proximity assay
This method uses scintillation proximity
assay for the detection of amplified DNA
instead of PAGE in TRAP. This modification
helps to increase the detection rate of
In combination with the traditional TRAP, it
helps increase the rate of detection of
telomerase activity
The major disadvantage of this method is the
use of tritium, and also like most methods for
detecting TRAP products without PAGE, it is
sensitive to PCR artifacts
[83, 98]
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Assay name Description of modification of original
assay
Benefits of modification Potential limitation References
telomerase activity. 5’-Biotin conjugated
oligonucleotides are used as substrate in this
method
TRAP with detection using the
hybridization protection assay
(hybridization protection assay-TRAP)
In this method, after PCR, the amplified
product is detected by the use of probes
labeled with covalently bound acridine
This modification is safer and easier to detect
telomerase product
[99]
TRAP with ELISA (enzyme-linked
immunosorbent assay
In this method, after the amplification,
concentration of DNA calorimetrically,
enhancing the qualitative and semi-
quantitative assessment of telomerase
activity
TRAP-ELISA method is faster as compared
with TRAP, which is based on the separation
of the amplified DNA in gel. This makes it
possible to use the TRAP-ELISA method in
screening studies
One of the drawbacks of this method is the
complexity in separating the telomerase-
positive and telomerase-negative controls,
which may result from the absence of
internal controls and two steps of signal
amplification
[100, 101]
TRAP with electrochemical detection This method involves the treatment of the
remaining PCR products after the initial PCR
with 3 M HCl making it possible to
determine dGMP (one of the products of the
complete hydrolysis of the amplified DNA)
This modification has no special advantages
over other methods in which no gel-
electrophoresis or radioactive labeling are
used
This method is more laborious and time
consuming
[102]
TRAP with real-time PCR This method employs the use of real time
PCR which permits the simultaneous
amplification of DNA and measurement of
the amount of amplified products after each
cycle. Combination of real time PCR with the
standard TRAP makes it possible to obtain
quantitative results and is suitable for
analysis of large samples
This modification allows to obtain
quantitative results. This modification is also
suitable for studying telomerase inhibitors
and analyzing large specimen series. The
advantages of this method include; a high
rate of detection of telomerase-synthesized
DNA upon flow analysis and enhanced
specificity due to the use of corresponding
probes
Over-estimation of telomerase activity and
leveling of small differences in the activity is
possible without the assessment of the
amount of real-time PCR products, due to
saturation of the PCR reaction in the final
stages. Also, there is the possibility of dimer
formation resulting in false-positive signal
[83, 87,
103–105]
In situ TRAP In this method, FITC-labeled primers (direct
and reverse) are used. Here the fluorescence
intensity and its localization in nucleus or
cytoplasm are used to determine telomerase
activity in separate cell types within a
mixture. High telomerase activity in
urogenital and bronchial lavages manifests
This modification allows for a semi-
quantitative determination of telomerase
activity and its localization in isolated cells of
tissues and cell suspensions
This method is only appropriate for cancer
cells and not suitable to study cell senescence
[106–111]
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Assay name Description of modification of original
assay
Benefits of modification Potential limitation References
itself through bright fluorescence of the
nuclei of malignant cells. The signal from
cytoplasm is detected in granulocytes and
macrophages
TRAP on microchips This method involves the combination of
two primer—TRAP and binding of PCR
products on chips, followed by probe
hybridization and detection using different
fluorescent labels to determine telomerase
synthesized DNA and the internal standard;
for example, Cy3 for the telomerase-
synthesized DNA being amplified and Cy5,
for the standard
The modification is that; the introduction of
microchips and hybridization using different
probes for the detection of telomerase
synthesized DNA
[83]
Transcription amplification of
telomerase-synthesized DNA
In this modification PCR is replaced by
transcription amplification, this is to increase
the amount of telomerase-synthesized DNA.
Combined with “hybridization protection,”
this method allows to determine the
telomerase activity within short time period.
The method’s sensitivity allows to detect
telomerase activity in specimens consisting
of 1–1000 cells and also sensitive to the
presence of RNases
The major advantage of this method over
TRAP with PCR amplification is that no
heating of a specimen is required upon
amplification and that the specific Taq
polymerase inhibitors are neglected. This
method makes it possible to semi-
quantitatively determine the telomerase
activity in tissue and cell line extracts
[83, 87,
112]
Table 1.
Different modifications of TRAP method for telomerase activity detection.
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Assay name Description of modification or original assay Benefits of modification Potential limitation or disadvantage References
Direct incorporation of a
radioactively labeled substrate
This method is based on the ability of
telomerase to elongate oligonucleotides in the
presence of dNTP. The oligonucleotide or the
dNTPs are radioactive labeled allowing the
detection of telomerase activity
electrophoretically by its incorporation into the
telomerase-synthesized DNA
The modification allows for qualitative
determination of the activity and processivity of
telomerase in cell line extracts. Absence of
artifacts associated with PCR. The telomerase-
synthesized DNA can be immediately observed
in the gel. Its size and amount can be estimated
The major disadvantage of this method includes
the use of large amounts of radioactive isotopes
with longer exposure time and insufficient
sensitivity
[83, 113]
Determination of telomerase-
synthesized DNA by changes in
surface plasmon resonance
Surface plasmon resonance (SPR) is used to
detect telomerase activity as the corresponding
elongation of a telomere-imitating
oligonucleotide, using a biosensor (5’-biotin-
conjugated) oligonucleotides, which contain
telomeric repeats, these are in situ immobilized
on the surface of a dextrane sensor pre-treated
with streptavidin on a BIACORE instrument
This method allows to quantitatively determine
telomerase activity in tissue and cell line
extracts and collect data on the kinetics of the
reaction, demonstrating the binding and
dissociation of telomerase from the substrate
The necessity of the BIACORE system and
biotin-conjugated primers
[83, 114, 115]
Oligo-modified magnetic particles
and NMR
This method involves the use of magnetic
particles of an iron oxide which are modified
with oligonucleotides that are complementary to
telomeric repeats. These particles bind to the
telomerase-synthesized repeats due to
complementary interactions and form extended
linear structures (MRS complexes). The local
distortion of the magnetic field increases on
nanoparticles in ordered ensembles, whereas the
nonordered nanoparticles provide a
considerably lower magnetic effect
This modification made it possible to analyze
large number of specimens within short period
of time (in several 10 of minutes) with high
sensitivity. There also absence of artifacts which
were associated with PCR. Radioactive label and
PAGE are not required
In addition to the common instruments and
reagents, these analyses require a plate NMR-
spectrometer and a specimen of oligonucleotide-
modified nanoparticles which are expensive
[83, 116]
Quartz crystal microbalance
technique
An Au-quartz resonator can be used for a
microgravitometrical analysis of telomerase
activity, according to the quartz crystal
microbalance technique. Here, in this method,
the telomere-imitating oligonucleotide is bound
to the surface of the sensor and is elongated by
telomerase
The method allows for the quantitative
determination of the telomerase activity in
tissue and cell line extracts. The sensitivity
threshold is up to 3300-cell extracts of the
telomerase-positive cell line at a high rate
A frequency analyzer and an Au-quartz crystal
need to be provided in this method. Also, the
identification of artifact signals is complicated
[117]
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Assay name Description of modification or original assay Benefits of modification Potential limitation or disadvantage References
Biobarcode assay for telomerase
activity detection
In the original biobarcode system, magnetic
particles bind to a target, which in turn binds to
nanoparticles covalently modified with an
oligonucleotide due to antigen–antibody
interactions. DNA nanoparticles consist of gold
nanoparticles and oligonucleotides of two types;
one of these can form a duplex with the
telomerase-synthesized DNA
This modification makes it most sensitive for
direct detection of telomerase activity without
amplification of the telomerase-synthesized
DNA. Whereas the second cannot. Because of
this, the probability of binding another DNA-
target to the same nanoparticle is reduced. The
electroactive complex [Ru(NH3)6]
3+, which is
capable of binding to negatively charged DNA
chains due to electrostatic interactions, is used
for detection
A modified electrode and nanoparticles coated
with oligonucleotides of two types are required
[118]
Optical biosensors assay The principle of this method is similar to that of
SPR. The method is based on the fact that upon
binding of a target, the refraction index on the
sensor’s surface changes in proportion to the
amount of bound targets
In this modification a cassette consisting of
three oligonucleotides helps to avoid steric
impediments. Phosphate groups covalently
interact with the surface via the 50-end of an
oligonucleotide. Then, an oligonucleotide
containing a short noncomplementary region on
its 30-end complementarily binds to the
immobilized DNA. The prominent 30-end of the
DNA is modified with phosphorothioate, which
enhances the affinity of telomerase-primer
binding by a factor of 10
Phosphorothioate-modified oligonucleotides
and a special optosensor are required. The low
sensitivity for clinical samples
[83, 119]
Quantum dots telomerase detection This method is based on a telomere-imitating
oligonucleotide modified at its end with the thio
group is attached to a nanoparticle (quantum
dot). This quantum dot is capable of fluorescing
by absorbing a quantum with a wavelength of λ1
(400 nm) and emitting a quantum with a
wavelength of λ1’ (560 nm)
This modification allows for a quantitative
assessment of the telomerase activity
The disadvantage is that the sensitivity
threshold is approximately 10,000 HeLa cells
which is not enough for an analysis of clinical
materials
[120]
An on-chip nanowire sensor assay This method involves the use a sensor chip (a
transistor comprising antibody-coated silicon
nanowires with aldehydes groups on their
surface, to which monoclonal antibodies can be
linked) to determine telomerase activity, the
transistor nanowire is modified by telomere-
imitating oligonucleotides instead of antibodies.
This modification allows to determine
telomerase activity in cell line extracts even
though, it has not been tested on clinical
materials. Its sensitivity is sixty five (65) T293
cells and the major advantage of this method is
that a large number of different analyses of one
specimen can be carried out on a single chip,
Here a transistor chip and the equipment to
analyze it are required
[121, 122]
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Assay name Description of modification or original assay Benefits of modification Potential limitation or disadvantage References
After the introduction of telomerase and dNTP,
the oligonucleotides bound on the surface
elongate, which results in change in the
conductivity of the transistor to which the
oligonucleotides are bound
which can be a set of sensors with respect to
various markers. Moreover, the stages of
telomerase binding and dissociation can be
observed
Bioluminescence method Bioluminescence method is used for the
determination of telomerase activity based on
the fact that the telomerase-catalyzed
elongation of the telomere-imitating
oligonucleotide is accompanied by the cleavage
of pyrophosphate; its amount is determined
luminometrically
The advantage of the method is the linear
dependence of the signal on the amount of
telomerase-synthesized DNA, combined with
high efficiency. The sensitivity and specificity of
this method can be comparable with the
sensitivity of TRAP-ELISA
A luciferase system for bioluminescence
detection and a luminometer are required
[123]
Electrochemiluminescence method Telomerase activity can also be determined by
electrochemiluminescence (luminescence upon
electrolysis). In this method, the 50-biotin-
conjugated primer is elongated by telomerase
followed by incubation with a suspension of
magnetic beads modified with avidin
This method allows for the quantitative
determination of telomerase activity in samples
that contain at least 500 HeLa cells. It provides
an appreciably high signal/noise ratio due to the
stage of magnetic bead extraction; however, it
has not been tested on clinical materials
Difficult to synthesize a sample, requirements to
the equipment
[83, 124]
FRET and total internal reflection
fluorescence microscopy method
This is a FRET-based method that is intended to
distinguish the single-letter synthesis (a
nonprocessive method of synthesis) and the
beginning of synthesis of the second DNA
repeat (a conditionally processive method of
synthesis) by individual complexes of
Tetrahymena thermophila telomerase. Biotin-
conjugated primers (TG)8 T2 G4 T2 were used
on streptavidin-coated quartz slides which were
treated with telomerase-containing extract in
the presence of dGTP and ddTTP
The method allows to identify individual signals
from the elongation of the primer by telomerase
and can be combined with FRET-based methods
to investigate telomerase structure
This method can be used to determine only the
first 1.5 telomerase-synthesized repeats; that is,
it does not reveal total telomerase activity. The
method has been tested only on T. thermophila
telomerase and has been aimed only at solving
research problems till date
[83, 125]
Table 2.
Methods for direct detection of telomerase-synthesized DNA.
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Telomere restriction
fragment (TRF)
analysis
Telomere restriction fragments (TRF) involves
Southern blot hybridization using probes against
telomere repeats used for the analysis
This technique is widely used and it requires no
special reagents or equipment
Quantification is very difficult. It requires large
number of cells (106). This method provides an
estimate of the average telomere length per
sample and produces subtelomeric
polymorphism
[52, 128]
qPCR The qPCR technique was first introduced by RM
Cawthon in 2002. The method involve detection
of telomeric DNA with fluorescent signals (T)
using partially mismatched primers in a 96-well
format on real time-quantitative PCR (qPCR)
platform. The measurement of the telomeric
DNA is normalized with a single-copy
housekeeping gene (S) that is amplified in same
sample in a different plate and T/S ratio
(measure of relative TL) is computed
In qPCR technique, relative TL can be assessed
within a short time and small amount of DNA
(20 ng per reaction) is required. This method is
widely used in epidemiological studies that
involve large number of samples
Studies have shown that there is wide range of
CVs (2–28%) for measurement of TL by qPCR
which suggests that repeatability is a concern
with the qPCR technique. Proper optimization of
qPCR conditions is required to reduce variability
[129, 130,
133–135]
Monochrome
multiplex qPCR
(MMqPCR)
It was established by the same person as qPCR.
This is an improved version of the qPCR method
in which both telomeric DNA and single-copy
gene are amplified in same well of a plate
In this method there is less variability compared
with monoplex qPCR and has lesser sample
requirement
Just like the qPCR proper optimization of
experimental conditions is required
[130]
Flow-fluorescence in
situ hybridization
(FISH) assay
Telomere length analysis by FISH is based on the
specific labeling of telomeres with fluorescent
peptide nucleic acid (PNA) oligonucleotide
probes
Increased sensitivity and specificity. It has ability
to measure telomere length at the single-cell
level
This method requires expensive equipment
which may not be found in many laboratories
and it is not possible to assess TL in tissues
(histological samples) and stored samples. The
assay typically requires cells to be at replicating
stage to analyze chromosomes in metaphases
rather than interphase cells
[131]
Single telomere length
analysis (STELA)
It is a ligation PCR-based method No specialized equipment is required and it
requires very limited starting material
The single telomere length analysis method is
also labor intensive and is again not appropriate
for the analysis of large number of samples
[132]
Table 3.
Different methods for measurement of telomere length.
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These modifications may include: rising of the rate of analysis, substitution of the
radioactive label by nonlabeled compounds, the decrease in the amount of side
products, and so on. A number of modifications still make it possible to detect
telomerase activity within a single cell [84]. The TRAP consists of three main stages:
primer elongation, amplification of telomerase-synthesized DNA, and finally, the
detection step. In the elongation step, telomeric repeats are added to the telomere-
imitating oligonucleotide (TS) by telomerase found in the cell extract. Next, PCR-
amplification of telomerase synthesized DNA is carried out using definite primers
(telomere-imitating and reverse primers). At this stage, different labels such as
radioactive or fluorescent labels can be incorporated into the synthesized DNA. This
step is then followed by detection through separation of PCR products by gel
electrophoresis and imaging) [83]. The original TRAP assay has several drawbacks.
Initially, the CX oligonucleotide, which complementarily overlaps with TS for sev-
eral base pairs (bp), is used in the amplification of PCR products which results in
the primer dimer formation as a result of the interaction between primers and
products [83]. The use of optimal ACX primer with the noncomplementary TS end
can lead to appearance of background signal during the analysis of concentrated
tissue extracts from tumor [85]. The use of an oligonucleotide TSG4 which can also
be added to the TRAP mixture in order to evaluate the effect of duplex-stabilizing
inhibitors. This oligonucleotide does not require the synthesis of several repeats by
telomerase before the inhibitor begins its action [86]. Various nucleotides used in
TRAP assay were discussed in more detail [87]. In addition, when PCR is used for
signal amplification, the PCR inhibitors contained in the specimen can alter the
results of telomerase activity detection [83]. Previously, in the TRAP method, PCR
products were detected in polyacrylamide gel (PAGE) with respect to the radioac-
tive label used, it can be introduced using a radioactively labeled primer or incor-
porated into the DNA during the preparation of the PCR reaction. This method
allows performing a qualitative assessment of the activity and processivity of telo-
merase in cells and tissue extracts [83]. In the second stage of TRAP, the PCR
product allows to obtain an amount of DNA sufficient for gel staining, for instance,
use of ethidium bromide [88], silver nitrite [89] and SYBR Green [90] and its
analogs (which has sensitivity equal to that of radioactive label [91], while mutage-
nicity is considerably higher than when ethidium bromide is used) (Tables 1 and 2).
4.3 Methods used for measurement of telomere length (TL)
Several researchers have shown interest in measuring telomere length (TL)
accurately and efficiently so as to understand both the fundamental biology of
telomere maintenance as well as factors which contributes significantly to acceler-
ated TL attrition. Tarik et al. [126, 127] have described different techniques which
were developed for telomere length measurement (Table 3).
5. Conclusions
Telomerase is a ribonucleoprotein complex, composed of a reverse transcriptase
enzyme catalytic subunit and a long non-coding RNA that contains the template
sequence for telomere synthesis and is required for linear chromosome maintenance
in most eukaryotes. Telomerase is a high-molecular weight RNP complex that
consists of two major components: TERC and a TERT. It was found that in humans;
only the TERT and TERC components of the telomerase are required for its activity
in vitro, even though some proteins which have regulatory function are also essen-
tial for the catalytic function of telomerase in vivo. It was estimated that about 32
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different proteins are involved with human telomerase in vivo which maintain its
functionality and only some of these proteins are phylogenetically preserved. The
molecular chaperones Hsp90 and p23, which directly associate with hTERT, are
present in rabbit reticulocyte lysates and are necessary for telomerase activity.
Studies suggest that in Tetrahymena the proteins p80 and p95 are not core telome-
rase components and may be separate ribonucleoproteins that copurified non-
specifically with telomerase. Telomerase remains active during early embryonic
development but expression declines after the blastocyst stage and can no longer be
detected in neonatal somatic cells.
Until recently, the activity of telomerase was thought to be controlled by limiting
access to the telomeres but it is regulated by some protein complexes such as the
shelterin complexes. Nevertheless, the cumulative information given in this chapter
show that the events involved in telomerase recruitment and its activation are
separate. Although, the organizational biology and biochemistry responsible for the
process of telomerase activation is still unknown which could be an important focus
area in future research. Telomerase activity is highly expressed in embryonic germ
cells, testes, ovaries and in some cancer cells but its activity is low or absent in
somatic cells. The expression of telomerase activity in cells indicates replicative
capability of that cell and this involves several factors which regulate the telomerase
activity. Towards understanding the biology of telomere, several methods have been
designed to measure the telomerase activity and the telomere length. TRAP was the
initial method deployed for the measurement of telomerase where the amplified
product is detected using gel electrophoresis. There are several other modifications
to the original TRAP which has more advantages, such as the qPCR amplification
method which uses less concentration of primers and permits quantitative determi-
nation of synthesized DNA. However, proper optimization of qPCR conditions is
required to achieve reproducibility of this method. There are various methods which
have been established for measurement of telomere length (TL) and these includes:
(i) terminal restriction fragment (TRF) analysis (the gold standard), (ii) flow-FISH
cytometry of cells following hybridization with fluorescent peptide nucleic acid
(PNA) probes, (iii) quantitative fluorescence in situ hybridization (FISH) with
fluorescent telomere PNA probes and (iv) qPCR assay. Monochrome multiplex
qPCR (MMqPCR) was also established which is an improved version of the qPCR
method in which both telomeric DNA and single-copy gene are amplified in a same
well of a plate which require lesser sample and shows less variability. Studies have
shown that there is wide range of CVs (2–28%) for measurement of TL by qPCR
which suggests that repeatability is a concern with the qPCR technique. Therefore,
proper optimization of qPCR protocols is required to reduce variability in the results.
Apart from the TRF assay all other methods have the problem of generating a
relative measure of TL.While the qPCR technique has more advantage where it requires
small amounts of DNA, less time consuming and can easily be performed in high-
throughput format which makes it possible to analyze large epidemiological samples.
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